Skip to content

Clinical trials

Recruiting Myeloproliferative Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Recruiting Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20211
20221
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Celgene1
Children's Oncology Group1
Cogent Biosciences, Inc.1
Damora Therapeutics1
Disc Medicine, Inc1
Jubilant Therapeutics Inc.1
Prelude Therapeutics Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders9
Primary Myelofibrosis5
Thrombocythemia, Essential4
Myelodysplastic Syndromes2
Neoplasms2
Polycythemia Vera2
Anemia1
Carcinoma in Situ1
Central Nervous System Neoplasms1
Desmoid Tumors1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.